FDA approves Gilead's Stribild

Singapore: The US Food and Drug Administration (FDA) has approved Stribild, a complete once-daily single tablet regimen ...

August 28, 2012 | Tuesday | Regulatory
BNC105 effective in treating cancer

Singapore: Bionomics is going to present clinical trial data from its ongoing US trial of BNC105 in patients with metast...

June 1, 2012 | Friday | News
QRxPharma pain killer's NDA gets FDA response

Singapore: QRxPharma received complete response letter (CRL) regarding the company's Moxduo new drug application (NDA) f...

August 28, 2013 | Wednesday | Regulatory
3SBio to develop JenKem's novel drug for cancer

Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...

September 18, 2014 | Thursday | News
Takeda to collaborate with BC Cancer Agency for new drugs

Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...

September 3, 2012 | Monday | News
Teva to acquire migraine drug firm at $825 mn

Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...

June 4, 2014 | Wednesday | News
Japan to help export regenerative medicine tech to Qatar, KSA

Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...

July 17, 2013 | Wednesday | News
Bayer receives approval for Gadovist injection in Japan

Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...

March 30, 2015 | Monday | News
New analysis of EndoBarrier reveals high efficacy

Singapore: Australia-based GI Dynamics has conducted a new meta-analysis that demonstrates EndoBarrier Therapy, an endos...

December 3, 2013 | Tuesday | News
Novartis announces positive results in COPD portfolio trials

Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...

September 4, 2012 | Tuesday | News
Korea Drug Development Fund collaborates with PAREXEL

Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...

July 20, 2012 | Friday | News
Non-small cell lung cancer therapeutics APAC market to touch $2.9 bn by 2019'

Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...

March 19, 2014 | Wednesday | Analysis
GSK announces failure of cancer drug trial

Singapore: Glaxosmithkline declared that the phase III study of two anti-HER2 agents lapatinib and trastuzumab did not m...

June 5, 2014 | Thursday | News
Singapore invests $60mn to set up nanomedicine research institute

Singapore: Focusing on the medical application of nanotechnology, Nanyang Technological University (NTU) in Singapore  ...

November 7, 2013 | Thursday | News
NIH to invest $100 mn on HIV research

Singapore: The National Institutes of Health (NIH), US, plans to invest an additional $100 million over the next three ...

December 3, 2013 | Tuesday | News
Clinical trial drugs must adopt highest GMP standards

Singapore: Almac said that Asian clinical trials must adopt highest GMP and GDP standards. Speaking to a news report, Mr...

April 24, 2014 | Thursday | News
Merck, Samsung to co-develop diabetes drug

Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...

February 11, 2014 | Tuesday | News
Excelra, H M Pharma to expand Drug Repurposing Solutions outreach in Europe

Excelra, headquartered in Hyderabad, India, has announced its collaboration with H M Pharma Consultancy (HMPC), a life s...

May 24, 2016 | Tuesday | News